Efficacy News and Research

RSS
Austrian AGES approves Baxter's PREFLUCEL vaccine for seasonal influenza

Austrian AGES approves Baxter's PREFLUCEL vaccine for seasonal influenza

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Unique genetic markers point to patient response to SCV-07 treatment

Unique genetic markers point to patient response to SCV-07 treatment

Keryx commences Zerenex Phase 3 study for hyperphosphatemia in patients with ESRD on dialysis

Keryx commences Zerenex Phase 3 study for hyperphosphatemia in patients with ESRD on dialysis

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

New program offers options for fertility preservation in children with cancer

New program offers options for fertility preservation in children with cancer

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

Malaria vaccine development meeting begins in Washington

Malaria vaccine development meeting begins in Washington

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Intrauterine devices for treatment of endometrial cancer

Intrauterine devices for treatment of endometrial cancer

CRP levels vary between ethnically-diverse populations: Study

CRP levels vary between ethnically-diverse populations: Study

Combination therapy reduces radiographic evidence of joint destruction in rheumatoid arthritis: Study

Combination therapy reduces radiographic evidence of joint destruction in rheumatoid arthritis: Study

XenoPort to present XP21279 clinical trial data at World Parkinson Congress meeting

XenoPort to present XP21279 clinical trial data at World Parkinson Congress meeting

Further trials needed to determine clinical application of Abatacept in SLE

Further trials needed to determine clinical application of Abatacept in SLE

New disposable, microfluidic PDMS device for identification of advanced breast cancer

New disposable, microfluidic PDMS device for identification of advanced breast cancer

HUYA, Quintiles announce agreement to develop HBI-8000 cancer drug

HUYA, Quintiles announce agreement to develop HBI-8000 cancer drug

PolyMedix begins PMX-30063 Phase 2 clinical trial for bacterial infections

PolyMedix begins PMX-30063 Phase 2 clinical trial for bacterial infections

Neuronix to present TMS treatment trial data for Alzheimer's disease at Geneva Congress

Neuronix to present TMS treatment trial data for Alzheimer's disease at Geneva Congress

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.